1[1]Murphy EF,Keddie JL,Lu JR,et al.The reduced adsorption of lysozyme at the phosphorylcholine incorporated polymer/aqueous solution interface studied by spectroscopic ellipsometry[J].Biomaterials,1999,20(16):1501-1511.
3[3]De Somer F,Francois K,van Oeveren W,et al.Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface[J].Eur J Cardiothorac Surg,2000,18(5):602-606.
4[4]Rubens FD,Mesana T.The inflammatory response to cardiopulmonary bypass:a therapeutic overview[J].Perfusion,2004,19:s5-12.
5[5]Baufreton C,Jansen PG,Le Besnerais P,et al.Heparin coating with aprotinin reduces blood activation during coronary artery operations[J].Ann Thorac Surg,1997,63(1):50-56.
6[6]Deppisch R,Gohl H,Smeby L.Microdomain structure of polymeric surfaces-potential for improving blood treatment procedures[J].Nephrol Dial Transplant,1998,13(6):1354-1359.
7[7]Rubens FD,Labow RS,Lavallee GR,et al.Hematologic evaluation of cardiopulmonary bypass circuits prepared with a novel block copolymer[J].Ann Thorac Surg,1999,67(3):689-698.
8[8]Suhara H,Sawa Y,Nishimura M,et al.Efficacy of a new coating material,PMEA,for cardiopulmonary bypass circuits in a porcine model[J].Ann Thorac Surg,2001,71(5):1603-1608.
9[9]Oudemans-van Straaten HM,Jansen PG,Hoek FJ,et al.Intestinal Permeability,circulating endotoxin,and postoperative systemic responses in cardiac surgery patients[J].J Cardiothorac Vasc Anesth,1996,10(2):187-194.
10[10]Schonberger JP,Everts PA,Hoffmann JJ.Systemic blood activation with open and closed venous reservoirs[J].Ann Thorac Surg,1995,59(6):1549-1555.
2[1]Sheeran P,Hall GM.Cytokines in anaesthesia[J].Br J Anaasth,1997,78(2):201 -219.
3[2]Laffey JG,Boylan JF,Chexg DC.The systemic inflammatory respense to cardiac surgery:implications for the Anesthesiologist[J].Anesthesiology,2002,97(1):215 -252.
4[3]Davies SW,Duffy JP,Wickens DG,et al.Time-course of free radical activity during coronary artery operations with cardiopulmonary bypass[J].J Thorac Cardiovasc Surg,1993,105 (6):979-987.
6[6]Stordeur P,Goldman M.Interleukin-10 as a regulatory cytokine induced by cellular stress:molecular aspects[J].Int Rev Immunol,1998,16(5 -6):501 -522.
7[7]McBride WT,Armstrong MA,Crockard AD,et al.Cytokine balance and immunosuppressive changes at cardiac surgery:Contrasting response between patients and isolated CPB circuits[J].Br J Anaesth,1995,75 (6):724-733.
8[8]Kawamura T,Wakausawa R,Okada K,et al.Elevation of cytokines during open heart surgery with cardiopulmonary bypass:Participation of interleukin 8 and 6 in reperfusion injury[J].Can J Anaesth,1993,40 (11):1016-1021.
9[9]Journois D,Israel -Biet D,Pouard P,et al.High volume,zero balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children[J].Anesthesiology,1996,85 (5):965-976.
10[10]Sato Y,Ishikawa S,Otaki A.Induction of acute-phase reactive substances during open-heart surgery and efficacy of ulinastatin.Inhibiting cytokines and postoperative organ injury[J].Jpn J Thorac Cardiovasc Surg,2000,48 (7):428-434.
